- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
VISTN
OSL
Week ended 07 Aug 2026
Weekly Investor Report
Vistin Pharma ASA · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
20.00 NOK
-1.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -3.1% below the Trend Line and sits at 26.0% of its 52-week range. The latest completed week returned -1.0%, after a -2.0% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
34
out of 100
Latest Close
20.00 NOK
7 Aug 2026
1W Return
-1.0%
latest completed week
4W Return
-2.0%
short-term follow-through
12W Return
-8.2%
quarterly tape
Trend Breadth
30.8%
16 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.0%
Latest completed week; four-week move -2.0%.
Indicator stack
17/29
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -3.1% below the Trend Line and sits at 26.0% of its 52-week range. The latest completed week returned -1.0%, after a -2.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1612-week average 0.52
12-week confirmation
Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.0% over four weeks, -8.2% over 12 weeks, and -14.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year16
Trend breadth30.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.98Latest activity-pressure read.
Pressure change-40.2%Four-week change in activity pressure.
Leadership-14.33Latest relative-leadership reading.
RS change-30.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-17.3%Distance below the 52-week high.
13-week volatility1.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 269 weeks finished lower.
Best week+5.2%Week of 27 Feb.
Worst week-3.6%Week of 6 Mar.
Latest week-1.0%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains11
Flat weeks4
Modest losses9
Sharp losses0
Recent vol1.6%13-week weekly-return volatility.
Base vol2.2%52-week weekly-return volatility.
Up/down split21/24Count of positive and negative weeks in the 52-week window.
Average skew1.7% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNO Healthcare
4-week rank20 / 24
Group average4.3%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD37.5%positive activity pressure
RS29.2%positive relative leadership
Four-week leaders
IndustryNO Drug Manufacturers - Specialty & Generic
4-week rank1 / 2
Group average-7.3%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape32/100
Trend, activity pressure, participation, and risk combine to a 32/100 tape read.
Indicator analysis31/100Latest 12-week confirmation: trend 6/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.16; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 20.00 NOK | -1.0% | 20.64 NOK | 20.93 NOK | -0.98 | -14.33 | 48.8K | Off |
| 31 Jul 2026 | 20.20 NOK | 1.0% | 20.65 NOK | 20.93 NOK | -0.89 | -13.79 | 38.5K | Off |
| 24 Jul 2026 | 20.00 NOK | -2.9% | 20.62 NOK | 20.92 NOK | -0.86 | -14.83 | 22.2K | Off |
| 17 Jul 2026 | 20.60 NOK | 1.0% | 20.61 NOK | 20.92 NOK | -0.70 | -10.69 | 73.5K | Off |
| 10 Jul 2026 | 20.40 NOK | 0.0% | 20.56 NOK | 20.91 NOK | -0.70 | -10.98 | 77.6K | Off |
| 3 Jul 2026 | 20.40 NOK | -1.4% | 20.53 NOK | 20.90 NOK | -0.68 | -12.01 | 1.9K | Off |
| 26 Jun 2026 | 20.70 NOK | 1.0% | 20.51 NOK | 20.90 NOK | -0.55 | -9.23 | 5.3K | On |
| 19 Jun 2026 | 20.50 NOK | 0.0% | 20.46 NOK | 20.88 NOK | -0.34 | -12.94 | 94 | On |
| 12 Jun 2026 | 20.50 NOK | 0.5% | 20.42 NOK | 20.87 NOK | 0.01 | -15.36 | 195 | On |
| 5 Jun 2026 | 20.40 NOK | -2.9% | 20.39 NOK | 20.86 NOK | 0.50 | -16.67 | 634.2K | On |
| 29 May 2026 | 21.00 NOK | -0.9% | 20.36 NOK | 20.86 NOK | 0.81 | -14.66 | 47.2K | On |
| 22 May 2026 | 21.20 NOK | -2.7% | 20.35 NOK | 20.86 NOK | 1.10 | -16.27 | 66.6K | On |
| 15 May 2026 | 21.78 NOK | 2.2% | 20.35 NOK | 20.85 NOK | 1.20 | -13.42 | 24.5K | On |
| 8 May 2026 | 21.30 NOK | -0.4% | 20.31 NOK | 20.83 NOK | 1.23 | -13.76 | 80.5K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.